An Analysis of the Controversy over Classical One-Sided Tests. Freedman, L. S. Clin Trials, 5:635-640, 2008. bibtex @article{fre08ana,
title = {An Analysis of the Controversy over Classical One-Sided Tests},
volume = {5},
journal = {Clin Trials},
author = {Freedman, Laurence S.},
year = {2008},
pages = {635-640},
citeulike-article-id = {13265719},
posted-at = {2014-07-14 14:10:02},
priority = {0},
annote = {"Using a Bayesian decision framework, it is shown that there is no reason to double the p-value when moving from a one-sided to a two-sided test. Within the classical framework, it is shown that the doubling of the p-value results from a discontinuity due to testing a point null hypothesis. A three-decision rule, credited to Neyman or Wald, is presented that does not require the doubling of the p-value, and is consistent with a Bayesian approach. For most comparative clinical trials the three-decision rule is appropriate, and its use would abolish the controversy over one-sided tests."}
}
Downloads: 0
{"_id":"7Ht9CWYGaK3akNynW","bibbaseid":"freedman-ananalysisofthecontroversyoverclassicalonesidedtests-2008","downloads":0,"creationDate":"2018-06-23T20:06:34.621Z","title":"An Analysis of the Controversy over Classical One-Sided Tests","author_short":["Freedman, L. S."],"year":2008,"bibtype":"article","biburl":"http://hbiostat.org/bib/harrelfe.bib","bibdata":{"bibtype":"article","type":"article","title":"An Analysis of the Controversy over Classical One-Sided Tests","volume":"5","journal":"Clin Trials","author":[{"propositions":[],"lastnames":["Freedman"],"firstnames":["Laurence","S."],"suffixes":[]}],"year":"2008","pages":"635-640","citeulike-article-id":"13265719","posted-at":"2014-07-14 14:10:02","priority":"0","annote":"\"Using a Bayesian decision framework, it is shown that there is no reason to double the p-value when moving from a one-sided to a two-sided test. Within the classical framework, it is shown that the doubling of the p-value results from a discontinuity due to testing a point null hypothesis. A three-decision rule, credited to Neyman or Wald, is presented that does not require the doubling of the p-value, and is consistent with a Bayesian approach. For most comparative clinical trials the three-decision rule is appropriate, and its use would abolish the controversy over one-sided tests.\"","bibtex":"@article{fre08ana,\n title = {An Analysis of the Controversy over Classical One-Sided Tests},\n volume = {5},\n journal = {Clin Trials},\n author = {Freedman, Laurence S.},\n year = {2008},\n pages = {635-640},\n citeulike-article-id = {13265719},\n posted-at = {2014-07-14 14:10:02},\n priority = {0},\n annote = {\"Using a Bayesian decision framework, it is shown that there is no reason to double the p-value when moving from a one-sided to a two-sided test. Within the classical framework, it is shown that the doubling of the p-value results from a discontinuity due to testing a point null hypothesis. A three-decision rule, credited to Neyman or Wald, is presented that does not require the doubling of the p-value, and is consistent with a Bayesian approach. For most comparative clinical trials the three-decision rule is appropriate, and its use would abolish the controversy over one-sided tests.\"}\n}\n\n","author_short":["Freedman, L. S."],"key":"fre08ana","id":"fre08ana","bibbaseid":"freedman-ananalysisofthecontroversyoverclassicalonesidedtests-2008","role":"author","urls":{},"downloads":0},"search_terms":["analysis","controversy","over","classical","one","sided","tests","freedman"],"keywords":["*import"],"authorIDs":[],"dataSources":["mEQakjn8ggpMsnGJi"]}